13 December 2017
News and Views
Links and Services
The latest issue of Alimentary Pharmacology & Therapeutics examines relapse after anti-TNF withdrawal for sustained remission in IBD.
Infliximab and adalimumab have established roles in inflammatory bowel disease (IBD) th
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors